Healthline15h
NSYNC’s Lance Bass Says Managing Type 1.5 Diabetes Is a 'Full-Time Job'
NSYNC’s Lance Bass shares his journey with type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA). The ...
Program designed by and for Aboriginal women sees 30% diabetes remission in participants
An innovative study, co-designed by Aboriginal Women, has led to remission of type 2 diabetes. The research described and ...
Futurism on MSN13h
Evidence Is Growing That Ozempic Can Cause Blindness
As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more cases linking them to ...
Healio5h
FDA approves subcutaneous Merilog for glycemic control in diabetes
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
Healio11h
Automated insulin delivery lowers HbA1c, improves time in range in type 2 diabetes
Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...
Frontiers13h
Technologies for Diabetes, volume III
Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...
drugdeliverybusiness8h
Insulet Omnipod 5 produces positive study outcomes in type 2 population
JAMA today published outcomes from a study evaluating the safety and efficacy of the Insulet Omnipod 5 in adults with type 2 ...